These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 9289697
1. [Prediction of pharmacological effect of octreotide in acromegaly by means of 111In-pentetreotide scintigraphy and calculation of a pituitary uptake index]. Görges R, Cordes U, Engelbach M, Bartelt KM, Haberern G, Hey O, Beyer J, Bockisch A. Nuklearmedizin; 1997 Jun; 36(4):117-24. PubMed ID: 9289697 [Abstract] [Full Text] [Related]
2. 111Indium-pentetreotide pituitary scintigraphy and hormonal responses to octreotide in acromegalic patients. Legovini P, De Menis E, Billeci D, Conti B, Zoli P, Conte N. J Endocrinol Invest; 1997 Jun; 20(7):424-8. PubMed ID: 9309542 [Abstract] [Full Text] [Related]
3. Results of somatostatin receptor scintigraphy do not predict pituitary tumor volume- and hormone-response to ocreotide therapy and do not correlate with tumor histology. Plöckinger U, Bäder M, Hopfenmüller W, Saeger W, Quabbe HJ. Eur J Endocrinol; 1997 Apr; 136(4):369-76. PubMed ID: 9150695 [Abstract] [Full Text] [Related]
17. [Somatostatin analogs in the clinical management of pituitary neoplasms]. Colao A, Dorato M, Pulcrano M, Rossi FW, Auriemma RS, Lombardi G, Lastoria S. Minerva Endocrinol; 2001 Sep; 26(3):181-91. PubMed ID: 11753242 [Abstract] [Full Text] [Related]
18. Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo. Duet M, Ajzenberg C, Benelhadj S, Lajeunie E, Lormeau B, Guillausseau PJ, Rohmer V, Vilain D, Mundler O, Warnet A. J Nucl Med; 1999 Aug; 40(8):1252-6. PubMed ID: 10450674 [Abstract] [Full Text] [Related]
19. Octreotide as primary therapy for acromegaly. Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL. J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397 [Abstract] [Full Text] [Related]
20. Scintigraphic assessment of pituitary adenomas and several diseases by indium-111-pentetreotide. Tumiati MN, Facchi E, Gatti C, Bossi A, Longari V. Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):98-100. PubMed ID: 9002761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]